Articles

September 7, 2012 — St. Jude Medical Inc. announced results of the FAME II trial demonstrating that patients with...

Verifynow platelet testing clopidogrel nonresponders

Patients with 2C19 that is less active due to loss of gene copies are poor metabolizers of clopidogrel, opening patients to the possibility of a higher rate of mayocardial infacrtion (...

The standard-of-care for dual antiplatelet therapy (DAPT) for more than a decade has been clopidogrel (Plavix) plus aspirin. This standard is now being challenged by new agents —...

Comedian Rosie O'Donnell’s heart attack last week is helping increase public education about how women’s myocardial infarction (MI) symptoms differ from men's. She posted a blog on Monday...

Trends and new technology for cardiac computed tomography angiography (CCTA) were highlighted during the 2012 Society of Cardiovascular CT (SCCT) annual scientific meeting in July in Baltimore, Md...

Each year, I find it interesting that some “new” technology being introduced by a vendor is actually an old, recycled idea.  

An unusual exhibitor that seemed very out of place on the expo floor of the Heart Rhythm Society 2012 annual meeting was Ford Motor Company.  Engineers, standing next to a brand new Ford...

The electrocardiogram (ECG) stress test remains one of the most widely used diagnostic tools for detecting coronary heart disease. While the basics of stress test systems have changed little since...

Over the past decade there have been several advancements in prothrombin time (PT)/international normalized ration (INR) point-of-care testing (POCT) devices. This is usually performed at an...